Stijn van Rompay
Fortune : 45 M $ au 31/05/2026
Fortune : 45 M $ au 31/05/2026
Stijn van Rompay was the founder of Uteron Pharma SA, founded in 2010, where the title held was General Manager from 2010 to 2015.
Mr. van Rompay is the founder of Hyloris Pharmaceuticals SA, founded in 2012, holding the title Chief Executive Officer & Executive Director starting in 2025.
Mr. van Rompay is also the founder of Alter Pharma Group NV.
Current jobs include Director at ImCyse SA since 2012, Managing Director & Director at EXO Biologics SA since 2019, and Managing Director & Director at Hyloris Developments SA since 2020.
Former jobs include Non-Executive Director at Coalesce Product Development Ltd. and Chief Financial Officer at Docpharma NV.
Education includes graduate degree from the University of Antwerp.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HYLORIS PHARMACEUTICALS SA 27,65 % | 31/12/2024 | 7 743 067 ( 27,65 % ) | 45 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| HYLORIS PHARMACEUTICALS SA | Fondateur | 01/01/2012 |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies | Directeur/Membre du Conseil | 01/01/2012 |
EXO Biologics SA
EXO Biologics SA BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | 29/08/2019 |
Hyloris Developments SA
Hyloris Developments SA Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Directeur Général | 20/04/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
Coalesce Product Development Ltd.
Coalesce Product Development Ltd. Medical SpecialtiesHealth Technology Develops inhalation devices | Directeur/Membre du Conseil | 27/09/2024 |
Uteron Pharma SA
Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Develops controlled release devices | Directeur Général | 01/08/2015 |
Alter Pharma Group NV
Alter Pharma Group NV Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Fondateur | - |
Docpharma NV
Docpharma NV Pharmaceuticals: MajorHealth Technology Provides generic drugs | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Docpharma NV
Docpharma NV Pharmaceuticals: MajorHealth Technology Provides generic drugs | Health Technology |
University of Antwerp
University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Uteron Pharma SA
Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Develops controlled release devices | Electronic Technology |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies | Health Technology |
Alter Pharma Group NV
Alter Pharma Group NV Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Hyloris Pharmaceuticals SA
Hyloris Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products by reformulating well-known drugs | Health Technology |
EXO Biologics SA
EXO Biologics SA BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Coalesce Product Development Ltd.
Coalesce Product Development Ltd. Medical SpecialtiesHealth Technology Develops inhalation devices | Health Technology |
Hyloris Developments SA
Hyloris Developments SA Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national